• Citer

Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.

par Bottomley, A;Biganzoli, Laura ;Cufer, T;Coleman, R;Coens, C;Efficace, F;Calvert, H;Gamucci, T;Twelves, C.;Fargeot, Pierre;Piccart-Gebhart, Martine ;European Organization for Research and Treatment of Cancer Breast Cancer Group,
Référence Journal of clinical oncology, 22, 13, page (2576-2586)
Publication Publié, 2004-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.
Auteur:	Bottomley, A; Biganzoli, Laura; Cufer, T; Coleman, R; Coens, C; Efficace, F; Calvert, H; Gamucci, T; Twelves, C.; Fargeot, Pierre; Piccart-Gebhart, Martine; European Organization for Research and Treatment of Cancer Breast Cancer Group,
Informations sur la publication:	Journal of clinical oncology, 22, 13, page (2576-2586)
Statut de publication:	Publié, 2004-07
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Cyclophosphamide -- administration & dosage
	Doxorubicin -- administration & dosage
	Fatigue
	Female
	Health Status
	Humans
	Infusions, Intravenous
	Injections, Intravenous
	Middle Aged
	Quality of Life
	Treatment Outcome
Note générale:	Clinical Trial
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2004.02.037
	info:pii/22/13/2576
	info:pmid/15226325